PATENT CLAIM ANALYSIS

Application Number: 16073746
Application Type: Utility
Filing Date: 2018-07
Publication Date: 2019-01
Patent Classification: ["514", "001400"]

Abstract:
A compound of Formula (I), and its analogs are provided. Compositions that include Formula I can be used to inhibit human equilibrative nucleoside transporter 1, increase adenosine signaling and produce effects that include increasing antiviral activity, increasing antiparasitic activity, increasing alcohol tolerance, decreasing pain protecting from ischemia as well as many other conditions.

Claim (Index 1):
A compound selected from the group consisting of one of the following: Peptide Residue 1 Residue 2 Residue 3 Residue 4 JW95-1  mGly dPro mGly Phe JW95-2 mAla dPro mGly Phe JW95-3  mLeu dPro mGly Phe JW95-4  mSer dPro mGly Phe JW95-5  mPhe dPro mGly Phe JW95-6  mGly dPro mAla Phe JW95-7  mAla dPro mAla Phe JW95-8  mLeu dPro mAla Phe JW95-9  mSer dPro mAla Phe JW95-10  mPhe dPro mAla Phe JW95-11 mGly dPro mLeu Phe JW95-12 mAla dPro mLeu Phe JW95-13 mLeu dPro mLeu Phe JW95-14 mSer dPro mLeu Phe JW95-15 mPhe dPro mLeu Phe JW95-16 mGly dPro mSer Phe JW95-17 mAla dPro mSer Phe JW95-18 mLeu dPro mSer Phe JW95-19 mSer dPro mSer Phe JW95-20 mPhe dPro mSer Phe JW95-21 mGly dPro mPhe Phe JW95-22 mAla dPro mPhe Phe JW95-23 mLeu dPro mPhe Phe JW95-24 mSer dPro mPhe Phe JW95-25 mPhe dPro mPhe Phe 95-15-1 mLeu dPro mPhe Phe 95-15-2 mdLeu dPro mPhe Phe 95-15-3 mLeu dPro mPhe dhoPhe 95-15-4 Leu dPro mPhe Phe 95-15-5 mlle dPro mPhe Phe 95-15-6 mNle dPro mPhe Phe 95-15-7 mLeu Pro mPhe Phe 95-15-8 mLeu Gly mPhe Phe 95-15-9 mLeu dPro mdPhe Phe 95-15-10 mLeu dPro Phe Phe 95-15-11 mLeu dPro mPhe dPhe 95-15-12 mLeu dPro mPhe hoPhe 95-15-13 mLeu dPro mPhe Phg 95-15-14 mLeu dPro mPhe PheF 95-15-15 mLeu dPro mPhe PheCl 95-15-16 mLeu dPro mPhe Phel 95-15-17 mLeu dPro mPhe Tyr 95-15-18 mLeu dPro mPhe TyrBu 95-15-19 mLeu dPro mPhe PheNO2 95-15-20 mLeu dPro mPhe mPhe 95-15-21 mLeu dPro mPhe Che 95-15-22 mLeu dPro mPhe Nal 95-15-23 mLeu dPro mPhe biPhe 95-15-13-2 mLeu dHoPro mPhe Phg 95-15-13-3 mLeu dPro Phe Phg 95-15-13-4 mLeu dPro Pyr Phg 95-15-13-5 mLeu dPro hoPhe Phg 95-15-13-6 mLeu dPro Phg Phg 95-15-13-7 mLeu dPro PheF Phg 95-15-13-8 mLeu dPro PheCl Phg 95-15-13-9 mLeu dPro Phel Phg 95-15-13-10 mLeu dPro Tyr Phg 95-15-13-11 mLeu dPro TyrOMe Phg 95-15-13-12 mLeu dPro PheNO2 Phg 95-15-13-13 mLeu dPro Cha Phg 95-15-13-14 mLeu dPro Nal Phg 95-15-13-15 mLeu dPro biPhe Phg JW9552Biotin mLeu dPro mPhe Phg

Metadata:
- Claim Count in Document: 1.0
- Percentile: 95.0
- Lexical Diversity: 1.29167
- Patent Class: 514.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['10558176', '12126810', '12742807', '14849782', '14898846']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7634362052041919
- 35 USC 102 Novelty (BERT): 0.5375087016935325
- Combined Prediction Score: 0.7408434548531259
- Mean Citation Score: 239.658688
- Max Citation Score: 308.34003
- Similarity Product: 134.8418449168235

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test